Most previous studies have demonstrated that versican expression is predictive of poor prognosis in many cancers, including breast, ovarian, cervical, prostate, endometrial, non-small cell lung cancer and astrocytoma. Here, VCAN is linked to astrocytoma (excluding glioblastoma).